Northwestern scientists said they found pancreatic cancer cells play a trick on a person's immune system by wearing a sugar ...

At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...

Wuhan YZY Biopharma Co., Ltd. Class H ( ($HK:2496) ) has issued an update. Wuhan YZY Biopharma has received Investigational New Drug approval from ...

A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing ...

Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.

Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), ...

Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour ...

A newly engineered antibody can penetrate kidney cysts and interrupt the growth signals that drive polycystic kidney disease.